nafazatrom has been researched along with Myocardial Infarction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, GD; Jolly, SR; Lucchesi, BR; Murtagh, JJ; Pitt, B; Shea, MJ | 1 |
| Fiedler, VB | 2 |
| Bednar, M; Mullane, KM; Pinto, A; Smith, B | 1 |
| Fiedler, VB; Mardin, M | 1 |
| Fiedler, VB; Grützmann, R; Mardin, M; Perzborn, E | 1 |
6 other study(ies) available for nafazatrom and Myocardial Infarction
| Article | Year |
|---|---|
Beneficial effects of nafazatrom on ischemic reperfused myocardium.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Fibrinolytic Agents; Male; Myocardial Infarction; Pyrazoles; Pyrazolones; Time Factors | 1984 |
Reduction of myocardial infarction and dysrhythmic activity by nafazatrom in the conscious rat.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Male; Myocardial Infarction; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains | 1983 |
Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Cell Aggregation; Coronary Disease; Dogs; Fibrinolytic Agents; Glucuronidase; Male; Myocardial Infarction; Myocardium; Neutrophils; Platelet Aggregation; Pyrazoles; Pyrazolones; Superoxides | 1985 |
Enhancement of canine coronary collateral flow by nafazatrom.
Topics: Animals; Cattle; Collateral Circulation; Coronary Circulation; Dogs; Female; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Infarction; Potassium; Pyrazoles; Pyrazolones; Vascular Resistance | 1986 |
The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Coronary Circulation; Disease Models, Animal; Dogs; Electrocardiography; Female; Male; Myocardial Infarction; Perfusion; Platelet Aggregation; Pyrazoles; Pyrazolones; Thromboxane B2 | 1985 |
Failure of nafazatrom to reduce infarct size and arrhythmias in a porcine model of acute coronary occlusion.
Topics: Animals; Arachidonate Lipoxygenases; Arrhythmias, Cardiac; Female; Fibrinolytic Agents; Hemodynamics; Lipoxygenase Inhibitors; Male; Myocardial Infarction; Pyrazoles; Pyrazolones; Swine | 1985 |